Translate the text from Welsh to English.



 
Mae Diwrnod Clefyd Llid y Coluddyn (IBD) y Byd yn ein hatgoffa bod clefyd Crohn's a cholitis briwiol yn anhwylderau cronig y coluddyn sy'n effeithio ar bobl ifanc yn bennaf, a all arwain at golli amser sylweddol mewn addysg ac yn y gweithle. Mae'r clefyd yn gofyn am driniaeth hirdymor gyda chyffuriau ac weithiau llawdriniaeth.


Sefydlwyd gweithgor IBD Cymru dair blynedd yn ôl a phenodwyd Arweinydd clinigol cenedlaethol ar gyfer gwasanaethau IBD, sef Dr Barney Hawthorne, i weithio gyda gwasanaethau'r GIG ledled Cymru i rannu arferion gorau a chefnogi gweithgareddau gwella ansawdd.  


Mae'r gweithgor bellach wedi cwblhau ei waith ac mae Diwrnod IBD y Byd yn gyfle priodol i gofnodi'r hyn sydd wedi’i gyflawni a pha weithgarwch sydd ar y gweill.


Cwblhawyd adolygiad manwl o wasanaethau IBD yng Nghymru yn 2020\. Fe wnaeth yr adolygiad ganfod nifer o heriau, megis amrywiad mewn ymarfer rhwng gwasanaethau'r byrddau iechyd, pwysau ar y gweithlu, ac anhawster cael mynediad at dimau IBD a gwasanaethau cymorth. Roedd hyn yn unol â chanfyddiadau arolwg meincnodi IBD ledled y DU yn 2019\.


Un o agweddau allweddol y gwaith oedd datblygu llwybr cenedlaethol i hybu mynediad cyson at brofion calprotectin ysgarthol mewn gofal sylfaenol. Defnyddir y prawf i fesur llid y perfedd a dyma'r ffordd fwyaf cyffredin y mae pobl ag IBD yn dod at y GIG. Mae'n bwysig bod pobl, ble bynnag y maent yn byw yng Nghymru, yn gallu cael y prawf cywir. Mae pob un o’r byrddau iechyd bellach yn gweithredu'r llwybr hwn.


Mae Iechyd a Gofal Digidol Cymru a thîm Gwerth mewn Iechyd Cymru wedi datblygu dangosfwrdd IBD \- adnodd digidol cenedlaethol sy'n dod â data cleifion a gesglir yn rheolaidd ynghyd i fesur gweithgarwch ac ansawdd, yn seiliedig ar Safonau IBD UK 2019\. Mae'r gwaith yn dal i fynd rhagddo ond mae ganddo’r potensial i helpu rheolwyr gwasanaethau lleol a thimau clinigol i wella gwasanaethau. Bydd yn darparu gwybodaeth bwysig am amseroedd aros, derbyniadau brys, cyfraddau cymhlethdod a marwolaeth. Bydd yn galluogi byrddau iechyd i wella gwasanaethau i gleifion ymhellach.


Gyda chymorth gan dîm Gwerth mewn Iechyd Cymru, bu cryn  ffocws ar ddatblygu deunydd addysgol i helpu pobl i reoli eu cyflwr. Mae hyn yn cynnwys fideos addysgol. Mae seminar addysgol ar\-lein ar gyfer pobl sydd newydd gael diagnosis o IBD wedi'i sefydlu hefyd.


Bu cydweithrediad parhaus ac agos â Crohn's \& Colitis UK. Lansiodd y sefydliad ymgyrch Diagnosis Cynharach ar gyfer Anhwylderau'r Perfedd Isaf yng Nghymru yr hydref diwethaf. Mae wedi’i thargedu at oedolion ifanc ac mae’n annog pobl â dolur rhydd, poen neu waedu i gael help yn gyflym. Fe'i cefnogir gan lwybr clinigol y cytunwyd arno ar gyfer ymchwilio i glefydau'r perfedd isaf (IBD, clefyd seliag, syndrom coluddyn llidus, canser y colon a llawer o anhwylderau eraill).


Yn sgil sefydlu Gweithrediaeth y GIG fis Ebrill, y bwriad yw sefydlu nifer o rwydweithiau clinigol cenedlaethol newydd i helpu i wella gwasanaethau’n barhaus. Bydd un o’r rhain ar gyfer gwasanaethau gastroberfeddol a bydd yn cynnwys grŵp gweithredu IBD, gydag arweinydd clinigol newydd yn dilyn ymddeoliad Dr Hawthorne. Hoffwn ddiolch i Dr Hawthorne am ei holl waith a dymuno'n dda iddo ar gyfer y dyfodol.







Translation:


 
World Inflammatory Bowel Disease (IBD) Day is a reminder that Crohn’s disease and ulcerative colitis are chronic bowel disorders predominantly affecting young people, which can result in significant loss of time in education, in the workplace, and requiring long\-term treatment with drugs and sometimes surgery.


A Wales IBD working group was set up three years ago and a national clinical Lead for IBD services, Dr Barney Hawthorne appointed to work with NHS services across Wales to share best practice and provide support to quality improvement activities.


The working group has now finished its work. World IBD Day is an appropriate moment to record what has been achieved and what activity is underway.


A detailed review of IBD services in Wales was completed in 2020\. It found a number of challenges, such as variation in practice between health board services, workforce pressures, and difficulty accessing IBD teams and support services. This was in line with the findings of the UK\-wide IBD benchmarking survey in 2019\.


A key focus of the work has been to develop a national pathway to encourage consistent access to faecal calprotectin testing in primary care. The test is used to measure gut inflammation and is the most common way people with IBD present to the NHS. It is important that people, wherever they live in Wales, have access to the right test. All health boards are now implementing this pathway.


Digital Health and Care Wales and the Wales Value in Healthcare team have developed an IBD dashboard – a national digital resource which brings together routinely collected patient data to measure activity and quality, based on the 2019 IBD UK Standards. This is still work in progress but has the potential to support local service managers and clinical teams to improve services. It will provide important information about waiting times, emergency admissions, rates of complication and mortality. It will enable health boards to further improve services.


With support from the Wales Value in Health team, there has been a lot of focus on developing educational material to help people manage their condition. This includes educational videos. An online educational seminar for people who have been newly diagnosed with IBD has also been established.


There has also been ongoing and close cooperation with Crohn’s and Colitis UK. The organisation launched an Earlier Diagnosis for Lower Gut Disorders campaign in Wales last autumn. It is targeted at young adults and urges people with diarrhoea, pain or bleeding to get help rapidly. It is supported by an agreed clinical pathway for the investigation of lower gut diseases (IBD, coeliac disease, irritable bowel syndrome, colonic cancer, and many other disorders).


Following the establishment of the NHS Executive in April, a number of new national clinical networks will be set up to support ongoing service improvement. Gastrointestinal services will form one of these, incorporating an IBD implementation group, with a new clinical lead, following Dr Hawthorne’s retirement. I would like to thank Dr Hawthorne for all his work and wish him well for the future.